Portugal Licencing Update

Following a detailed application process, EuroCan is pleased to confirm that it has recently been awarded a Medicinal Cannabis “pre-licence” from the Portuguese National Authority of Medicines and Health Products (“INFARMED”). As expected, the Health Authority in Portugal has been extremely collaborative and supportive during this time (especially in light of the COVID-19 constraints and restrictions), again confirming management’s views that Portugal is the right choice of jurisdiction for its initial European operations, in terms of legal & regulatory matters.

The award of this licence represents a major step forward for EuroCan’s plans and allows its local subsidiary, CECO Wellness, to embark upon the next workstreams involved in constructing its planned state-of-the-art Medicinal Cannabis facility in Portugal. The new facility, once completed, will comprise:

• a commercial greenhouse facility which meets the Good Agricultural Collection Practices (“GACP“) regulations, for the production of raw cannabis plant material; and

• a 1,350m² single storey building designed to achieve compliance with “Part II – Basic Requirements for Active Substances used as Starting Materials” of Volume 4 of the EudraLex  Good Manufacturing Practice guidelines (“EU GMP“) in relation to the future expansion to establish cannabis extraction processing facilities with R&D activities.

At present, the EuroCan team is working with one of Portugal’s largest engineering companies to finalise the conceptual design and is poised to commence architectural works, all of which are necessary to expedite the required related planning, licensing, design and industrial activity permissions from the relevant official authorities. This conceptual design work will enable EuroCan to fully evaluate and assess the solutions proposed and to achieve the necessary GACP and EU GMP specifications.

Miguel Fagundes

Head Pharmacist, Eurocan